Albireo Pharma Inc. (ALBO) Event Oct. 31, 2022, 07:34 UTC 106 0 comments Albireo Pharma Inc - Albireo Provides Third Quarter 2022 Business Update Comment Full text
Mersana Therapeutics (MRSN) Event Oct. 31, 2022, 07:03 UTC 92 0 comments Mersana Therapeutics - Mersana Third Quarter 2022 Earnings Call Comment Full text
Cytokinetics Inc (CYTK) Event Oct. 31, 2022, 06:30 UTC 82 0 comments Cytokinetics Announces Three Upcoming Presentations at the American Heart Association Scientific Sessions 2022 Comment Full text
Compugen Ltd (CGEN) Event Oct. 31, 2022, 06:06 UTC 100 0 comments Compugen - Compugen Third Quarter 2022 Financial Results and Corporate Update Comment Full text
Nevro Corp. (NVRO) Event Oct. 28, 2022, 23:40 UTC 81 0 comments Nevro Corp. Website - Validate Account Comment Full text
Aptinyx Inc. (APTX) Event Oct. 28, 2022, 14:45 UTC 77 0 comments Aptinyx Inc. - Aptinyx Reports Third Quarter 2022 Financial Results and Highlights Comment Full text
Biomerica Inc. (BMRA) Event Oct. 28, 2022, 10:40 UTC 99 0 comments Biomerica, Inc. - Investor Presentation Comment Full text
Genmab (GMAB) Event Oct. 28, 2022, 06:46 UTC 79 0 comments Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) Comment Full text
Mereo BioPharma (MREO) Event Oct. 28, 2022, 05:11 UTC 77 0 comments Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management Comment Full text
Avantor Inc. (AVTR) Event Oct. 28, 2022, 04:06 UTC 79 0 comments Avantor - Avantor Third Quarter Earnings Comment Full text